Vicore Pharma Holding AB (VICO) Stock Statistics & Valuation Metrics

Vicore Pharma Holding AB has a market cap or net worth of kr2.70B. The enterprise value is kr2.64K.

Vicore Pharma Holding AB has 281,644,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vicore Pharma Holding AB’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -41.20%.

The current PE Ratio of Vicore Pharma Holding AB is ―. Vicore Pharma Holding AB’s PEG ratio is -0.03.

In the last 12 months, Vicore Pharma Holding AB had revenue of 3.82M and earned -477.47M in profits. Earnings per share was -1.99.

In the last 12 months, operating cash flow was -455.43M and capital expenditures 355.04M, giving a free cash flow of -299.51M billion.

Vicore Pharma Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―

Vicore Pharma Holding AB upcoming earnings date is Nov 5, 2026, TBA (Confirmed).

Vicore Pharma Holding AB as a current ratio of 10.31, with Debt / Equity ratio of 0.00%

In the past 12 months, Vicore Pharma Holding AB has paid 0.00 in taxes.

Vicore Pharma Holding AB EV to EBITDA ratio is -4.47, with an EV/FCF ratio of -5.68.

Vicore Pharma Holding AB has kr905.64M in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr905.64M billion.

Gross margin is 80.97%, with operating margin of -11905.82%, and net profit margin of -12509.14%.

The average price target for Vicore Pharma Holding AB is kr38.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy